Market closedNon-fractional

VolitionRX/VNRX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About VolitionRX

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Ticker

VNRX

Sector

Healthcare

Trading on

AMEX

Industry

Health Care Equipment and Supplies

Headquarters

Henderson, United States

Employees

108

VolitionRX Metrics

BasicAdvanced
$61M
Market cap
-
P/E ratio
-$0.46
EPS
1.26
Beta
-
Dividend rate
$61M
1.26
0.428
0.378
-24.961
-33.378
-142.72%
-117.82%
359.94%
70.233
-3.84
-3.78
-3.006
133.06%
-17.47%
174.77%
1.75%

What the Analysts think about VolitionRX

Analyst Ratings

Majority rating from 3 analysts.
Buy

VolitionRX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-8,300.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$100K
-50.00%
Net income
-$8.3M
-3.49%
Profit margin
-8,300.00%
93.02%

VolitionRX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 9.09%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.14
-$0.11
-$0.11
-$0.10
-
Expected
-$0.15
-$0.13
-$0.11
-$0.11
-$0.10
Surprise
-5.08%
-15.38%
3.12%
-9.09%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for VolitionRX stock?

VolitionRX (VNRX) has a market cap of $61M as of July 23, 2024.

What is the P/E ratio for VolitionRX stock?

The price to earnings (P/E) ratio for VolitionRX (VNRX) stock is 0 as of July 23, 2024.

Does VolitionRX stock pay dividends?

No, VolitionRX (VNRX) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next VolitionRX dividend payment date?

VolitionRX (VNRX) stock does not pay dividends to its shareholders.

What is the beta indicator for VolitionRX?

VolitionRX (VNRX) has a beta rating of 1.26. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell VolitionRX stock

Buy or sell VolitionRX stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing